Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Differences in Transcriptomic Profiles of Brain and Thyroid Tumors with NTRK Gene Rearrangement. / Kechin, A. A.; Koryukov, M. A.; Smertina, M. A. и др.
в: Bulletin of Experimental Biology and Medicine, Том 175, № 1, 05.2023, стр. 78-85.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Differences in Transcriptomic Profiles of Brain and Thyroid Tumors with NTRK Gene Rearrangement
AU - Kechin, A. A.
AU - Koryukov, M. A.
AU - Smertina, M. A.
AU - Borobova, V. S.
AU - Oscorbin, I. P.
AU - Ivanov, A. A.
AU - Bakharev, S. Yu
AU - Boyarskikh, U. A.
AU - Kushlinskii, N. E.
AU - Filipenko, M. L.
N1 - The work was supported by the Russian Science Foundation (grant No. 20-15-00418; Investigation of the Molecular Mechanisms of the Development of Resistance of Tumor Cells with Chimeric NTRK Proteins to Tyrosine Kinase Inhibitors In Vitro). Публикация для корректировки.
PY - 2023/5
Y1 - 2023/5
N2 - For tumors with chimeric NTRK genes, entrectinib and larotrectinib can be prescribed regardless of tumor localization. We compared changes in the transcriptional activity of genes in brain tumors (BT) and thyroid cancer (TC) with rearrangement (NTRK+) and without rearrangement (NTRK-) of the NTRK genes using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. We revealed an increase in the transcription of the JUN gene in NTRK+ samples in comparison with NTRK- samples: by 1.6 times for BT (p=0.239) and by 2.5 times for TC (p=0.003). The transcription of eight HOX genes in NTRK+ BT samples was also increased (by 85-725 times, p
AB - For tumors with chimeric NTRK genes, entrectinib and larotrectinib can be prescribed regardless of tumor localization. We compared changes in the transcriptional activity of genes in brain tumors (BT) and thyroid cancer (TC) with rearrangement (NTRK+) and without rearrangement (NTRK-) of the NTRK genes using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. We revealed an increase in the transcription of the JUN gene in NTRK+ samples in comparison with NTRK- samples: by 1.6 times for BT (p=0.239) and by 2.5 times for TC (p=0.003). The transcription of eight HOX genes in NTRK+ BT samples was also increased (by 85-725 times, p
KW - NTRK
KW - brain tumor
KW - glioma
KW - neurotrophin receptors
KW - thyroid cancer
KW - MicroRNAs/genetics
KW - Neoplasms/pathology
KW - Humans
KW - Transcriptome
KW - Brain Neoplasms/genetics
KW - Thyroid Neoplasms/genetics
KW - Brain/pathology
KW - Gene Rearrangement
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85162273531&origin=inward&txGid=79f792e504cc875644ea7c9dc1bab756
UR - https://www.mendeley.com/catalogue/cbb2731f-0aac-31ea-b1d4-f2693b7b5a24/
U2 - 10.1007/s10517-023-05815-0
DO - 10.1007/s10517-023-05815-0
M3 - Article
C2 - 37335445
VL - 175
SP - 78
EP - 85
JO - Bulletin of Experimental Biology and Medicine
JF - Bulletin of Experimental Biology and Medicine
SN - 0007-4888
IS - 1
ER -
ID: 59627433